4MT-01 Series

N/A

Report date: 2024/03/14 15:24:37

Base Information

Drug Name4MT-01 Series
Drug Alias Name4MT-01 Series
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsAgitationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4M Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies4M Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAgitationAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A